Skip to search formSkip to main contentSkip to account menu

transcainide

Known as: 4-(dimethylamino)-N-(2,6-dimethylphenyl)-1-(2-hydroxycyclohexyl)-4-piperidinecarboxamide 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Lidocaine

Narrower (1)

R 54718
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Evaluation of the efficacy and tolerance of the antiarrhythmic agent transcainide (R 54718)
SummaryThe antiarrhythmic efficacy of transcainide has been studied in 41 patients. It abolished ventricular arrhythmias in 10… 
1992
1992
Clinical and electrophysiologic studies of R61748 (transcainide): a new class Ic antiarrhythmic drug.
The electrophysiology and antiarrhythmic efficacy of R61748, a 4-OH metabolite of R54718 (transcainide), have been studied in… 
1988
1988
Slowly Developing Activation Block of Cardiac Sodium Channels by a Lidocaine Analog, Transcainide
The working mechanism of Na+ channel block by a lidocaine analog, transcainide, was investigated. The Na+ channel block was… 
1987
1987
Sodium Channel Block by a Potent, New Antiarrhythmic Agent, Transcainide, in Guinea Pig Ventricular Myocytes
Transcainidse is a new lidocaine analog that has been shown to suppress a range of cardiac arrhythmias in an initial clinical… 
1987
1987
Electrophysiologic, antiarrhythmic and hemodynamic effects of transcainide.
Transcainide was selected as an antiarrhythmic drug with potential clinical application. In isolated dog, sheep and rabbit… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)